Universe Pharmaceuticals INC (UPC)

CIK 1809616 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Universe Pharmaceuticals INC.

Recent SEC filings

FiledFormAccession number
Oct 9, 2026EFFECT9999999995-26-003207
Oct 6, 20266-K0001213900-26-107197
Sep 29, 2026F-30001213900-26-104659
Sep 3, 20266-K/A0001213900-26-097225
Sep 1, 2026SCHEDULE 13G0001213900-26-096339
Sep 1, 2026SCHEDULE 13G0001213900-26-096336
Sep 1, 2026SCHEDULE 13G0001213900-26-096333
Sep 1, 2026SCHEDULE 13G0001213900-26-096331
Sep 1, 2026SCHEDULE 13G0001213900-26-096335
Sep 1, 2026SCHEDULE 13G0001213900-26-096340
Sep 1, 2026SCHEDULE 13G0001213900-26-096332
Sep 1, 20266-K0001213900-26-096306
Sep 1, 2026SCHEDULE 13G0001213900-26-096334
Jul 31, 20266-K0001213900-26-083956
Jul 29, 20266-K0001213900-26-082789
Jun 26, 20266-K0001213900-26-072603
May 21, 2026SCHEDULE 13D0001213900-26-060059
May 21, 202640001213900-26-060060
May 14, 20266-K0001213900-26-056617
Apr 16, 20266-K0001213900-26-044641
Mar 18, 202630001213900-26-029865
Mar 18, 202630001213900-26-029851
Mar 18, 202630001213900-26-029872
Mar 18, 202630001213900-26-029879
Mar 18, 202630001213900-26-029843